TANG CAPITAL MANAGEMENT LLC - 02 Oct 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share
Symbol
CBIO
Shares outstanding
13,888,889 shares
Disclosed Ownership
700,000 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
09 Oct 2025, 16:15:11 UTC
Date of event
02 Oct 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 5% ownership in Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO) on 02 Oct 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO).
  • Disclosed ownership: 5%.
  • Date of event: 02 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 09 Oct 2025, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5% 700,000 0 700,000 /s/ Kevin Tang Manager
KEVIN TANG 5% 700,000 0 700,000 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 2.8% 393,681 0 393,681 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2.2% 306,319 0 306,319 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer

Sponsored